Clinical trial

Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)

NCT00913029

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-05-01

PhasePHASE4

Study timeline

Study start (unknown)2009-05-01Date precision: month

Registry last updated2015-05-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Eye Diseasesunresolved

Glaucoma, Open-Angleunresolved

Glaucomaunresolved

Interventions

iStentDEVICE

latanoprost/timololDRUG

Sponsors & collaborators

Glaukos Corporationlead sponsor

Mapped research locations

MadridSpain1 ParisFrance1 WarsawPoland1 LyonFrance1 ViennaAustria1 ThessalonikiGreece1 ZaragozaSpain1 AlicanteSpain1 ErlangenGermany1 BochumGermany1 TorinoItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00913029 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.